Le Lézard
Classified in: Health
Subjects: CHI, WOM, POL, AVO

$1 Bil. Cut to HIV/AIDS Will Roll Back Progress, Threatens Mothers and Children


WASHINGTON, May 23, 2017 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) expresses deep concern with the proposed cuts to U.S. foreign assistance in the President's FY 2018 budget. Reductions of this magnitude will jeopardize strategic U.S. investment, as well as the goal of ending AIDS in children globally.

EGPAF is the global leader in the fight against pediatric HIV/ AIDS and has reached more than 20 million women with services to prevent transmission of HIV to their babies. It currently supports more than 7,000 health facilities and works in 15 countries to implement prevention, care, and treatment services; to further advance innovative research; and to execute global advocacy activities that bring dramatic change to the lives of millions of women, children, and families worldwide. (PRNewsFoto/Elizabeth Glaser Pediatric...)

Large decreases in U.S. foreign assistance funding, like the cuts recommended in the president's plan, won't just roll back hard-fought progress, but will hurt significant numbers of women, children, and families that have benefited from life-saving HIV prevention, care, and treatment services.

As Congress and the Administration determine the future of this vital funding, it's important to recognize that each dollar spent by the United States fighting HIV and AIDS has a direct and considerable impact on the daily health and survival of people in need. If EGPAF were required to absorb even a 10% reduction to our annual budget, it would significantly impact those served by our programs ? resulting in 56 additional infant HIV infections and 119 additional adult deaths due to HIV each week. These are real consequences for real people. To halt the remarkable progress we've made to date would not only be irresponsible, but could seriously jeopardize active efforts to end AIDS in children by 2020.

Since 2000, there has been an astonishing 70 percent decline in the number of new HIV infections in children worldwide, much of that due to America's leadership. However, important work remains. Every day 400 children are newly infected with HIV, and only 49 percent of the 1.8 million children living with HIV have access to the medications they need to stay alive and healthy.

The human cost of the cuts in the president's proposed budget will be substantial and should not be underestimated. Sustained commitment, investment, and prioritization are critical to continuing this progress and removing the final hurdles to our goal of ending AIDS in children. We urge Congress to preserve full funding for U.S. foreign assistance programs.

About the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)
EGPAF is the global leader in the fight against pediatric HIV/ AIDS and has reached more than 26 million women with services to prevent transmission of HIV to their babies. EGPAF is currently supporting activities in 19 countries and more than 5,000 sites to implement prevention, care, and treatment services; to further advance innovative research; and to execute global advocacy activities that bring dramatic change to the lives of millions of women, children, and families worldwide. For more information, visit www.pedaids.org.

Media Contact:
Meghan Quinn
[email protected]
202-448-8470

SOURCE Elizabeth Glaser Pediatric AIDS Foundation


These press releases may also interest you

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...



News published on and distributed by: